Loading viewer...
report
Format: PDF report
This report presents interim results from an open-label extension study of Antolimab for treating Eosinophilic Gastritis and Duodenitis, highlighting its investigational status.
presentation
report
Autogrill Group
report
Experian
report
Microsoft
report
Deloitte